Is Chios mastic gum effective in the treatment of functional dyspepsia? A prospective randomised double-blind placebo controlled trial

被引:50
|
作者
Dabos, Konstantinos J. [1 ]
Sfika, Ekaterini [1 ]
Vlatta, Lisa J. [1 ]
Frantzi, Despoina [1 ]
Amygdalos, Georgios I. [2 ]
Giannikopoulos, Georgios [3 ]
机构
[1] Chios Gen Hosp Skylits, Dept Gastroenterol, Chios, Greece
[2] Chios Gen Hosp Skylits, Dept Gen & Abdominal Surg, Chios, Greece
[3] Chios Gen Hosp Skylits, Dept Internal Med, Chios, Greece
关键词
Chios mastiha; Pistacia lentiscus var. chia cv; Anacandiacaeae; Hong Kong index of dyspepsia; Abdominal pain; Heartburn; IRRITABLE-BOWEL-SYNDROME; HELICOBACTER-PYLORI ERADICATION; CONTROLLED CROSSOVER TRIAL; NONULCER DYSPEPSIA; MULTICENTER TRIAL; PEPPERMINT-OIL; PISTACIA; EFFICACY; METAANALYSIS; FAMOTIDINE;
D O I
10.1016/j.jep.2009.11.021
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Herbal remedies are increasingly popular for the treatment of functional dyspepsia. Chios mastic gum is a resinous exudate from the stem of Pistacia lentiscus var. chia. It is a traditional natural remedy used throughout the eastern Mediterranean. The aim of this study was to assess the efficacy of Chios mastic gum in patients with functional dyspepsia. Methods: One hundred and forty eight patients fulfilling Rome 11 criteria for functional dyspepsia were randomly assigned to receive either Chios mastic gum 350 mg three times daily or placebo. After 3 weeks of treatment the change from baseline in the severity of symptoms of functional dyspepsia was assessed using the Hong Kong index of dyspepsia. Patients' global assessment of efficacy was also evaluated. Results: The symptom score after treatment was significantly lower in the Chios mastic gum than in the placebo group ((14.78 +/- 1.78) vs (19.96 +/- 1.83)) (p < 0.05). There was a marked improvement of symptoms in 40% of patients receiving placebo and in 77% of patients receiving Chios mastic gum (p < 0.02). Individual symptoms that showed significant improvement with Chios mastic gum were: stomach pain in general, stomach pain when anxious, dull ache in the upper abdomen and heartburn (<0.05 for all four symptoms). Conclusion: Chios mastic gum significantly improves symptoms in patients with functional dyspepsia compared to placebo. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:205 / 209
页数:5
相关论文
共 50 条
  • [1] Is mastic gum effective in the treatment of functional dyspepsia? A randomised double-blind placebo controlled trial
    Dabos, K. J.
    Sfika, E.
    Vlatta, L. J.
    Frantzi, D.
    Amygdalos, G. I.
    Giannikopoulos, G.
    GUT, 2007, 56 : A31 - A31
  • [2] Famotidine in the treatment of functional dyspepsia: a randomized double-blind, placebo-controlled trial
    Amini, Mohsen
    Chehreh, Mohammad Ebrahim Ghamar
    Khedmat, Hossein
    Valizadegan, Ghasem
    Babaei, Marzieh
    Darvishi, Ahmad
    Taheri, Saeed
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION, 2012, 87 (1-2): : 29 - 33
  • [3] Rifaximin for the treatment of functional dyspepsia: a double-blind randomized placebo-controlled trial
    Tan, V.
    Liu, K.
    Lam, F.
    Hung, I.
    Yuen, M.
    Leung, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 154 - 154
  • [4] Trimebutine Maleate Monotherapy for Functional Dyspepsia: A Multicenter, Randomized, Double-Blind Placebo Controlled Prospective Trial
    Kountouras, Jannis
    Gavalas, Emmanuel
    Papaefthymiou, Apostolis
    Tsechelidis, Ioannis
    Polyzos, Stergios A.
    Bor, Serhat
    Diculescu, Mircea
    Jadallah, Khaled
    Tadeusz, Mazurek
    Karakan, Tarkan
    Bochenek, Anna
    Rozciecha, Jerzy
    Dabrowski, Piotr
    Sparchez, Zeno
    Sezgin, Orhan
    Gulten, Macit
    Abu Farsakh, Niazy
    Doulberis, Michael
    MEDICINA-LITHUANIA, 2020, 56 (07): : 1 - 12
  • [5] DOUBLE-BLIND PLACEBO CONTROLLED TRIAL OF NICOTINE GUM AND PSYCHOLOGICAL TREATMENT
    HALL, SM
    JONES, RT
    TUNSTALL, C
    GINSBERG, D
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 22 (06) : 1085 - 1085
  • [6] Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial
    Cheong, Pui Kuan
    Ford, Alexander C.
    Cheung, Cynthia K. Y.
    Ching, Jessica Y. L.
    Chan, Yawen
    Sung, Joseph J. Y.
    Chan, Francis K. L.
    Wu, Justin C. Y.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (12): : 837 - 844
  • [7] Evaluation of antioxidant treatment in presbyacusis: prospective, placebo-controlled, double-blind, randomised trial
    Polanski, J. F.
    Cruz, O. L.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2013, 127 (02): : 134 - 141
  • [8] Treatment of functional dyspepsia with a herbal preparation - A double-blind, randomized, placebo-controlled, multicenter trial
    Madisch, A
    Holtmann, G
    Mayr, G
    Vinson, B
    Hotz, J
    DIGESTION, 2004, 69 (01) : 45 - 52
  • [9] Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial
    Wauters, Lucas
    Slaets, Helena
    De Paepe, Kim
    Ceulemans, Matthias
    Wetzels, Suzan
    Geboers, Karlien
    Toth, Joran
    Thys, Wannes
    Dybajlo, Raf
    Walgraeve, Daan
    Biessen, Erik
    Verbeke, Kristin
    Tack, Jan
    Van de Wiele, Tom
    Hellings, Niels
    Vanuytsel, Tim
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (10): : 784 - 792
  • [10] A DOUBLE-BLIND CONTROLLED CLINICAL-TRIAL OF MASTIC AND PLACEBO IN THE TREATMENT OF DUODENAL-ULCER
    ALHABBAL, MJ
    ALHABBAL, Z
    HUWEZ, FU
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1984, 11 (05) : 541 - 544